On November 25, 2008, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Savient Pharmaceuticals, Inc.. The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market …